Session Information
Session Time: None. Available on demand.
Disclosures: Taylor A. Colon, DO: No financial relationships or conflicts of interest
Objective: To align proton pump inhibitors (PPIs) use with best practices during IPR admissions.
Design: Case control study, Action ResearchSetting : Academic Inpatient Rehabilitation FacilityParticipants : 200 patients admitted to an IPR facility over 5 months were examined retrospectively. PPI prescribing trends were explored 3 months prior to intervention and 2 months following IPR provider education.
Interventions: An educational session on best-practice indications for PPIs, including ideal therapeutic dosage and duration was provided to IPR physicians and pharmacists. Patients in whom PPIs were discontinued were provided informational brochures with alternative pharmacologic and non-pharmacologic therapies to manage any symptoms.
Main Outcome Measures: A retrospective review of IPR records was performed in order to determine utilization of PPIs during IPR. Further categorization was based on factors including timing of prescription (i.e. prior to admission, upon admission, and whether it was continued upon discharge).
Results: Pre-intervention: A 3-month retrospective pre-intervention review showed that 131 patients were prescribed PPIs during IPR. 71% of these patients were previously prescribed PPIs and 29% were started during admission. Usage was discontinued in only 21% of patients prior to discharge, resulting in 79% of patients discharging from IPR with prescriptions for PPIs. Post-intervention: A 2-month post-intervention review revealed that 69 patients were prescribed PPIs during IPR. 71% of these patients were on PPIs upon admission and 29% started during admission. PPIs were stopped in 49% of these patients during IPR, resulting in 51% of these patients discharging with PPI prescriptions.Conclusions: Education for patients and physicians regarding the best-practice guidelines of PPIs lead to a 28% decrease of prescriptions upon discharge from an IPR facility. This simple intervention can further lead to improved patient safety and lower prescription costs for the IPR facility and patient.
Level of Evidence: Level III
To cite this abstract in AMA style:
Colon TA, Gill B, Farmer H, Jones V, Grahl C, Martin WP. Provider and Patient Education Limits the Usage of Proton Pump Inhibitors During Inpatient Rehabilitation [abstract]. PM R. 2021; 13(S1)(suppl 1). https://pmrjabstracts.org/abstract/provider-and-patient-education-limits-the-usage-of-proton-pump-inhibitors-during-inpatient-rehabilitation/. Accessed May 12, 2025.« Back to AAPM&R Annual Assembly 2021
PM&R Meeting Abstracts - https://pmrjabstracts.org/abstract/provider-and-patient-education-limits-the-usage-of-proton-pump-inhibitors-during-inpatient-rehabilitation/